Very early assessment of risk for in-hospital death among 11,483 patients with acute myocardial infarction

American Heart Journal

Volumn 138, Issue 6 I, 1999, Pages 1058-1064

  Fresco, C ^a   Carinci, F ^a   Maggioni, A P ^a   Ciampi, A ^a   Nicolucci, A ^a   Santoro, E ^a   Tavazzi, L ^a   Tognonia, G ^a  

^a Istituto di Cardiologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART INFARCTION LOCALIZATION; HEART MUSCLE REPERFUSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CODING; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0032711454     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70070-0     Document Type: Article

References (25)

1. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967;20:457-64.
2. Peel AF, Semple T, Wang I, Lancaster WM, Dall JL. A coronary prognostic index for grading the severity of infarction. Br Heart J 1962;24:745-60.
3. Effectiveness of intravenous thrombolytic therapy in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet 1986;1:397-401.
4. A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Soprevvivenza nell'Infarto Miocardico (GISSI-2). Lancet 1990;336:65-71.
5. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. The International Study Group. Lancet 1990;336:71-5.
6. A randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs heparin alone among 41299 suspected cases of acute myocardial infarction. Third International Study of Infarct Survival Collaborative Group. Lancet 1992;339:753-70.
7. Randomized comparison of intravenous atenolol among 16027 cases of suspected acute myocardial infarction. First International Study of Infarct Survival Collaborative Group. Lancet 1986;2:57-66.
8. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Soprevvivenza nell'Infarto Miocardico (GISSI-3). Lancet 1994;343:1115-22.
9. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993;328:673-9.
10. Ciampi A, Hogg S, McKiney S, Thiffaut J. RECPAM: a computer program for recursive partitioning and amalgamation for censored survival data and other situations frequently occurring in biostatistics; I: methods and program features. Comput Methods Programs Biomed 1988;26:239-56.
11. Ciampi A. Constructing prediction trees from data: the RECPAM approach. Proceedings from the Prague 1991 summer school on computational aspects of model choice. Heidelberg (Germany): Physica-Verlag; 1994. p. 105-52.
12. Carinci F, Nocolucci A, Ciampi A, Labbrozzi D, Bettinardi O, Zotti AM, et al. Role of interactions between psychological and clinical factors in determining 6-month mortality among patients with acute myocardial infarction: application of recursive partitioning techniques to the GISSI-2 data-base. Eur Heart J 1997;18:835-45.
13. Pilote L, Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarctions. N Engl J Med 1996;335:1198-205.
14. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley; 1990.
15. Ciampi A, Negassa A, Lou Z. Tree structured prediction for censored survival data and the Cox model. J Clin Epidemiol 1995;48:675-89.
16. SAS language version 6. Cary, N.C.: SAS Institute; 1990.
17. Lee KL, Woodlief LH, Topol EJ, Weaver D, Betruu A, Col J, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. GUSTO-1. Circulation 1995;91:1659-68.
18. Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A, et al. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. TIMI. Circulation 1992;85:1254-64.
19. Maggioni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E, et al. Age-related increase in mortality among patients with first myocardial infarction treated with thrombolysis. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med 1993;329:1442-8.
20. Braunwald E. Myocardial reperfusion: limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: should the paradigm be expanded? Circulation 1989;79:441-4.
21. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO Investigators. N Engl J Med 1993;329:673-82.
22. Simoons ML, Arnold AER. Tailored thrombolytic therapy: a perspective. Circulation 1993;88:2556-64.
23. Boersma H, Van der Vlugt MJ, Arnold AER, Deckers JW, Simoons ML. Estimated gain in life expectancy: a simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction. Eur Heart J 1996;17:64-75.
24. Determinants of cost for Acute myocardial infarction: a report from the Myocardial Infarction Cost Study (MICS). J Am Coll Cardiol 1994;166A:888-51.
25. Newby LK, Califf RM, Guerci A, Weaver WD, Col J, Horgan JH, et al. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol 1996;27:625-32.